Vincent Rajkumar

Vincent Rajkumar

UNVERIFIED PROFILE

Are you Vincent Rajkumar?   Register this Author

Register author
Vincent Rajkumar

Vincent Rajkumar

Publications by authors named "Vincent Rajkumar"

Are you Vincent Rajkumar?   Register this Author

100Publications

1843Reads

27Profile Views

Use of Bone-Modifying Agents Among Medicare Beneficiaries With Multiple Myeloma.

JAMA Oncol 2019 Dec 12. Epub 2019 Dec 12.

Division of Surgical Oncology, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.5426DOI Listing
December 2019

Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma.

Haematologica 2019 Oct 7;104(10):2061-2074. Epub 2019 Mar 7.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.211110DOI Listing
October 2019

Community-Based Study of Celiac Disease Autoimmunity Progression in Adults.

Gastroenterology 2019 Sep 24. Epub 2019 Sep 24.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2019.09.006DOI Listing
September 2019

Surrogate endpoints in randomised controlled trials: a reality check.

Lancet 2019 Jul;394(10195):281-283

Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)31711-8DOI Listing
July 2019

MAIA under the microscope - bringing trial design into focus.

Nat Rev Clin Oncol 2019 06;16(6):339-340

Division of Hematology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-019-0198-0DOI Listing
June 2019

Multiple myeloma: Every year a new standard?

Hematol Oncol 2019 Jun;37 Suppl 1:62-65

Division of Hematology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2586DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570407PMC
June 2019

Robert A. Kyle, MD: Lessons From a Legend.

Mayo Clin Proc 2019 03;94(3):375-376

Division of Hematology, Mayo Clinic, Rochester, MN. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2019.01.030DOI Listing
March 2019

Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing.

Blood 2019 02 26;133(7):652-659. Epub 2018 Dec 26.

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-08-825349DOI Listing
February 2019

Molecular signatures of multiple myeloma progression through single cell RNA-Seq.

Blood Cancer J 2019 01 3;9(1). Epub 2019 Jan 3.

Genome Analysis Core, Medical Genome Facility, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0160-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318319PMC
January 2019

Smoldering Multiple Myeloma: To Treat or Not to Treat.

Cancer J 2019 Jan/Feb;25(1):65-71

From the Division of Hematology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000350DOI Listing
January 2019

Authors' Reply.

J Am Soc Nephrol 2018 12 2;29(12):2902. Epub 2018 Nov 2.

Department of Pathology, Columbia University, College of Physicians and Surgeons, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2018101003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287876PMC
December 2018

Current, Emerging, and Anticipated Therapies for Sickle Cell Disease.

Mayo Clin Proc 2018 12;93(12):1703-1706

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2018.10.010DOI Listing
December 2018

Response to 'Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression'.

Leukemia 2018 09 25;32(9):2083-2085. Epub 2018 May 25.

Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0155-4DOI Listing
September 2018

The multiple myelomas - current concepts in cytogenetic classification and therapy.

Nat Rev Clin Oncol 2018 07;15(7):409-421

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-018-0018-yDOI Listing
July 2018

The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases.

J Am Soc Nephrol 2018 07 27;29(7):1810-1823. Epub 2018 Apr 27.

Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2017121319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050917PMC
July 2018

The importance of bone marrow examination in patients with light chain amyloidosis achieving a complete response.

Leukemia 2018 05 30;32(5):1243-1246. Epub 2018 Jan 30.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0022-3DOI Listing
May 2018

Value and Cost of Myeloma Therapy.

Am Soc Clin Oncol Educ Book 2018 May;38:662-666

From the Division of Hematology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_200867DOI Listing
May 2018

Reply to Castillo et al.

Am J Hematol 2018 03 5;93(3):E71-E73. Epub 2018 Feb 5.

Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25029DOI Listing
March 2018

Cast Nephropathy and Deceptively Low Absolute Serum Free Light Chain Levels: Resolution of a Challenging Case and Systematic Review of the Literature.

Clin Lymphoma Myeloma Leuk 2018 01 3;18(1):e1-e7. Epub 2017 Oct 3.

Clinic for Hematology, Oncology, and Stem Cell Transplantation, University Hospital, Freiburg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.09.019DOI Listing
January 2018

How I manage monoclonal gammopathy of undetermined significance.

Blood 2018 01 28;131(2):163-173. Epub 2017 Nov 28.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-09-807560DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757684PMC
January 2018

Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance.

N Engl J Med 2018 01;378(3):241-249

From the Divisions of Hematology (R.A.K., A.D., S.K., S.V.R.), Biostatistics (D.R.L., T.M.T.), and Epidemiology (J.R.C.), Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1709974DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852672PMC
January 2018